BRIEF-Astrazeneca's U.S. Trial Of COVID-19 Vaccine Has Completed Enrollment
- Country:
- United States
AstraZeneca PLC: * ASTRAZENECA PLC'S U.S. TRIAL OF CORONAVIRUS VACCINE HAS COMPLETED ENROLLMENT: PRESENTATION SLIDES AT U.S. CDC'S ACIP MEETING
* ASTRAZENECA'S U.S. TRIAL OF COVID-19 VACCINE ENROLLED 32,459 PARTICIPANTS, OUT OF WHICH 26,327 RECEIVED SECOND DOSE BY JAN 21: PRESENTATION SLIDES * ASTRAZENECA'S U.S. TRIAL OF COVID-19 VACCINE ENROLLED 11.2% HISPANIC/LATIN PARTICIPANTS, 9.8% BLACK OR AFRICAN AMERICAN, 5.3% ASIAN, 1.8% AMERICAN INDIAN Further company coverage:
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- AFRICAN AMERICAN
- AstraZeneca PLC
- U.S.
Advertisement